Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Cytolytic activity against primary leukemic cells by inhibitory NK cell receptor (CD94/NKG2A)-expressing T cells expanded from various sources of blood mononuclear cells

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Moretta A, Biassoni R, Bottino C, Pende D, Vitale M, Poggi A . Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev 1997; 155: 105–117.

    Article  CAS  Google Scholar 

  2. Phillips JH, Gumperz JE, Parham P, Lanier LL . Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 1995; 268: 403–405.

    Article  CAS  Google Scholar 

  3. Mingari MC, Ponte M, Bertone S, Schiavetti F, Vitale C, Bellomo R et al. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. Proc Natl Acad Sci USA 1998; 95: 1172–1177.

    Article  CAS  Google Scholar 

  4. Braud VM, Allan DS, O'Callaghan CA, Soderstrom K, D'Andrea A, Ogg GS et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998; 391: 795–799.

    Article  CAS  Google Scholar 

  5. Tanaka J, Toubai T, Tsutsumi Y, Miura Y, Kato N, Shintarou Umehara et al. Cytolytic activity and regulatory functions of inhibitory NK cell receptor-expressing T cells expanded from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood 2004; 104: 768–774.

    Article  CAS  Google Scholar 

  6. Raulet DH . Roles of the NKG2D immunoreceptor and its ligands. Nature Rev 2003; 3: 781–790.

    CAS  Google Scholar 

  7. Farag SS, George SL, Lee EJ, Baer M, Dodge RK, Becknell B et al. Postremission Therapy with Low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: cancer and leukemia Group B Study 9420. Clin Cancer Res 2002; 8: 2812–2819.

    CAS  PubMed  Google Scholar 

  8. Salih HR, Antropius H, Gieseke F, Lutz SZ, Kanz L, Rammensee HG et al. Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia. Blood 2003; 102: 1389–1396.

    Article  CAS  Google Scholar 

  9. Wang J, Springer TA . Structural specializations of immunoglobulin superfamily members for adhesion to integrins and viruses. Immunol Rev 1998; 163: 197–215.

    Article  CAS  Google Scholar 

  10. Groh V, Wu J, Yee C, Spies T . Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 2002; 419: 734–738.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Ms M Mayanagi for her technical assistance. This work was supported in part by a grant from the Idiopathic Hematological Disease and Bone Marrow Transplantation Research Committee of the Ministry of Health and Welfare of Japan and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture, Japan and by grants from Kirin Brewery Company, Chugai Pharmaceutical Company and Kyowa Hakko Pharmaceutical Company (Tokyo, Japan).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J Tanaka.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tanaka, J., Iwao, N., Toubai, T. et al. Cytolytic activity against primary leukemic cells by inhibitory NK cell receptor (CD94/NKG2A)-expressing T cells expanded from various sources of blood mononuclear cells. Leukemia 19, 486–489 (2005). https://doi.org/10.1038/sj.leu.2403611

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403611

This article is cited by

Search

Quick links